Saluda Medical Inc
Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeut… Read more
Saluda Medical Inc (SLD) - Net Assets
Latest net assets as of : AU$- AUD
Based on the latest financial reports, Saluda Medical Inc (SLD) has net assets worth AU$- AUD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$-) and total liabilities (AU$-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Saluda Medical Inc - Net Assets Trend (None–None)
This chart illustrates how Saluda Medical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Saluda Medical Inc (None–None)
The table below shows the annual net assets of Saluda Medical Inc from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Saluda Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Saluda Medical Inc Competitors by Market Cap
The table below lists competitors of Saluda Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
POLYONE
MU:PY9
|
$296.96K |
|
Immunovia AB
LSE:0G8X
|
$297.15K |
|
VOLVO -B- - Dusseldorf Stock Exchang
DU:VOL1
|
$297.24K |
|
Kermode Resources Ltd
PINK:KMDRF
|
$297.47K |
|
Shaftesbury Capital PLC
LSE:SHC
|
$296.56K |
|
SW UMWELTTECHNIK
BE:SWU
|
$296.46K |
|
Holobeam Inc
PINK:HOOB
|
$296.40K |
|
MURPHY OIL - Dusseldorf Stock Exchang
DU:MUQ
|
$296.26K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Saluda Medical Inc's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Saluda Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Saluda Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Saluda Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $14,750,885
- Average return on equity (ROE) among peers: -315.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Saluda Medical Inc (SLD) | AU$- | N/A | N/A | $296.82K |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.03 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $2.37 Million |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $92.74 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.96 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.98 Million |
| Cardiex Ltd (CDX) | $3.03 Million | -101.61% | 0.73x | $4.25 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $13.08 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $7.01 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.47 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |